Metrikler
Yayın
160
Açık Erişim
32
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1984 - 1990
1984 - 1990Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Türkiye
1975 - 1981
1975 - 1981Lisans
Ankara Üniversitesi, Tıp Fakültesi, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
Nöroloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (125)
SCI-E, SSCI, AHCI (110)
SCI-E, SSCI, AHCI, ESCI (123)
ESCI (13)
Scopus (119)
TRDizin (23)
2025
20251. Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experience
ÇAKAN ERCAN M., Demirel E., ÇİMEN B., ACAR ÖZEN N. P., Colpak I., Karabudak R., et al.
JOURNAL OF NEUROIMMUNOLOGY
, 2025 (SCI-Expanded, Scopus)
2025
20252. Evaluating Motor Imagery Capabilities in Fatigued Versus Non-Fatigued Individuals With Multiple Sclerosis Without Cognitive Impairment
Sekercan G., FİL BALKAN A., YETKİN M. F., Karabudak R., Tuncer A., SALCI Y.
NEUROREHABILITATION AND NEURAL REPAIR
, 2025 (SCI-Expanded, Scopus)
2025
20253. Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families
Buyukgol F., GÜRDAMAR B., ALUÇLU M. U., BECKMANN Y., Bilguvar K., BOZ C., et al.
SCIENTIFIC REPORTS
, sa.1, 2025 (SCI-Expanded, Scopus)
2025
20254. Can serum C3/C4 complement ratio be used in the differential diagnosis of central nervous system demyelinating diseases?
ÇAKAN ERCAN M., ÇİMEN B., ACAR ÖZEN N. P., SARA M. Y., KARABUDAK R., Tuncer A.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, 2025 (SCI-Expanded, Scopus)
2024
20245. Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis
Hartung H., Benedict R. H. B., Berger T., Bermel R. A., Brochet B., Carroll W. M., et al.
NEUROLOGY
, cilt.103, sa.12, 2024 (SCI-Expanded, Scopus)
2024
20246. Long-term Safety and Efficacy of Rituximab in Autoimmune Central Nervous System Disorders: Insights from a Single-Center Cohort
Ozbek E. D., Acar N. P., ÇOLPAK IŞIKAY A. İ., Tan E., KARABUDAK R., TUNCER M. A.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.1102-1103, 2024 (SCI-Expanded, Scopus)
2024
20247. Vaccination Strategies In Individuals With Multiple Sclerosis: Delphi Consensus
ÇİNAR B. P., Tuncer A., ÇETİNKAYA L., Aluclu U., BECKMANN Y., BOZ C., et al.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.829-830, 2024 (SCI-Expanded, Scopus)
2024
20248. Evaluation of Myeloid-Derived Suppressor Cells in Newly Diagnosed MS Patients
Acar N. P., Yanik H., ESENDAĞLI G., KARABUDAK R., TUNCER M. A.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.887-888, 2024 (SCI-Expanded, Scopus)
2024
20249. A standardised definition of progression independent of relapse activity in multiple sclerosis
Mueller J., Sharmin S., Lorscheider J., Ozakbas S., KARABUDAK R., Horakova D., et al.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.442-445, 2024 (SCI-Expanded, Scopus)
2024
202410. Choroid Plexus Enlargement and Associated Thalamus Atrophy Initiate in Radiologically Isolated Syndrome
Ozbek E. D., Acar N. P., Gormus M., KAYA K., AKÇİÇEK E., Bachhuber F., et al.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.1251, 2024 (SCI-Expanded, Scopus)
2024
202411. ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial
Hartung H., Berger T., Bermel R. A., Brochet B., Carroll W. M., Holmoy T., et al.
JOURNAL OF NEUROLOGY
, cilt.271, sa.7, ss.4348-4360, 2024 (SCI-Expanded, Scopus)
2024
202412. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis
Aprea M. G., Schiavetti I., Portaccio E., Ballerini C., Bonavita S., Buscarinu M., et al.
MULTIPLE SCLEROSIS JOURNAL
, cilt.30, sa.6, ss.707-713, 2024 (SCI-Expanded, Scopus)
2024
202413. Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study
Spelman T., Simoneau G., Hyde R., Kuhelj R., Alroughani R., Ozakbas S., et al.
Neurology
, cilt.102, sa.7, 2024 (SCI-Expanded, Scopus)
2024
202414. Navigating the discontinuation of multiple sclerosis first line treatments: A paradigm shift in patient care
Ozen N. P. A., Dursun E. G., Tuncer A., KARABUDAK R.
Multiple Sclerosis and Related Disorders
, cilt.84, 2024 (SCI-Expanded, Scopus)
2024
202415. Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study
Öztürk B., Taşkıran E., Demir S., TUNCER M. A., KÜRTÜNCÜ M., KARABUDAK R., et al.
Multiple Sclerosis Journal
, 2024 (SCI-Expanded, Scopus)
2024
202416. The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study
Levitz D., Foong Y. C., Sanfilippo P., Spelman T., Rath L., Roldan A., et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
, cilt.17, 2024 (SCI-Expanded, Scopus)
2024
202417. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Li Y., Saul A., Taylor B., Ponsonby A., Simpson-Yap S., Blizzard L., et al.
Journal of neurology
, cilt.271, sa.1, ss.472-485, 2024 (SCI-Expanded, Scopus)
2024
202418. Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry
Signori A., Ponzano M., Kalincik T., Ozakbas S., Horakova D., Havrdova E. K., et al.
Journal of Neurology, Neurosurgery and Psychiatry
, 2024 (SCI-Expanded, Scopus)
2023
202319. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
Diouf I., Malpas C. B., Sharmin S., Roos I., Horakova D., Kubala Havrdova E., et al.
Journal of neurology, neurosurgery, and psychiatry
, cilt.94, sa.12, ss.1004-1011, 2023 (SCI-Expanded, Scopus)
2023
202320. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Sharmin S., Roos I., Simpson-Yap S., Malpas C., Sánchez M. M., Ozakbas S., et al.
Brain : a journal of neurology
, cilt.146, sa.11, ss.4633-4644, 2023 (SCI-Expanded, Scopus)
2023
202321. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment
Sen S., Tuncer A., Terzi M., BÜNÜL S. D., Ozen-Acar P., Altunrende B., et al.
Multiple Sclerosis and Related Disorders
, cilt.79, 2023 (SCI-Expanded, Scopus)
2023
202322. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
Lebrun-Frénay C., SİVA A., Sormani M. P., Landes-Chateau C., Mondot L., Bovis F., et al.
JAMA neurology
, cilt.80, sa.10, ss.1080-1088, 2023 (SCI-Expanded, Scopus)
2023
202323. Reliability and validity of the glittre activities of daily living test in fully ambulatory multiple sclerosis patients
Kaya G., KÖSE N., SALCI Y., ARMUTLU K., Karakaya J., Tuncer A., et al.
Irish Journal of Medical Science
, cilt.192, sa.5, ss.2379-2386, 2023 (SCI-Expanded, Scopus)
2023
202324. Disability accrual in primary and secondary progressive multiple sclerosis
Harding-Forrester S., Roos I., Nguyen A., Malpas C. B., Diouf I., Moradi N., et al.
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.94, sa.9, ss.707-717, 2023 (SCI-Expanded, Scopus)
2023
202325. Sars-CoV2 infection in pregnant women with multiple sclerosis
Aprea M. G., Schiavetti I., Portaccio E., Ballerini C., Battaglia M. A., Bergamaschi R., et al.
Multiple Sclerosis Journal
, cilt.29, sa.9, ss.1090-1098, 2023 (SCI-Expanded, Scopus)
2023
202326. Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study
Cohen M., Thomel-Rocchi O., SİVA A., Okuda D. T., KARABUDAK R., EFENDİ H., et al.
Multiple Sclerosis Journal
, cilt.29, sa.9, ss.1099-1106, 2023 (SCI-Expanded, Scopus)
2023
202327. Is cancer risk reduced in multiple sclerosis? Results from a tertiary referral center
BAHAR Y., YILDIZ E., Bahar A. R., KARABUDAK R.
Turkish Journal of Medical Sciences
, cilt.53, sa.4, ss.962-969, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202328. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Kalincik T., Sharmin S., Roos I., Freedman M. S., Atkins H., Burman J., et al.
JAMA Neurology
, cilt.80, sa.7, ss.702-713, 2023 (SCI-Expanded, Scopus)
2023
202329. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
Tütüncü M., Demir S., Arslan G., Dinç Ö., Şen S., GÜNDÜZ T., et al.
Multiple Sclerosis and Related Disorders
, cilt.75, 2023 (SCI-Expanded, Scopus)
2023
202330. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Daruwalla C., Shaygannejad V., ÖZAKBAŞ S., Havrdova E. K., Horakova D., Alroughani R., et al.
Multiple sclerosis (Houndmills, Basingstoke, England)
, cilt.29, sa.7, ss.875-883, 2023 (SCI-Expanded, Scopus)
2023
202331. The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
BOZ C., ÖZAKBAŞ S., Terzi M., KARABUDAK R., Sevim S., Turkoglu R., et al.
Neurological Sciences
, cilt.44, sa.6, ss.2121-2129, 2023 (SCI-Expanded, Scopus)
2023
202332. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
Diouf I., Malpas C. B., Sharmin S., Roos I., Horakova D., Havrdova E. K., et al.
European Journal of Neurology
, cilt.30, sa.4, ss.1014-1024, 2023 (SCI-Expanded, Scopus)
2023
202333. External validation of a clinical prediction model in multiple sclerosis
Moradi N., Sharmin S., Malpas C. B., Shaygannejad V., Terzi M., BOZ C., et al.
Multiple Sclerosis Journal
, cilt.29, sa.2, ss.261-269, 2023 (SCI-Expanded, Scopus)
2023
202334. Comparative effectiveness in multiple sclerosis: A methodological comparison
Roos I., Diouf I., Sharmin S., Horakova D., Havrdova E. K., Patti F., et al.
Multiple Sclerosis Journal
, cilt.29, 2023 (SCI-Expanded, Scopus)
2023
202335. Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Spelman T., Magyari M., Butzkueven H., van der Walt A., Vukusic S., Trojano M., et al.
FRONTIERS IN NEUROLOGY
, cilt.14, 2023 (SCI-Expanded, Scopus)
2023
202336. The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis
Şen S., Arslan G., Tütüncü M., Demir S., Dinç Ö., GÜNDÜZ T., et al.
Noropsikiyatri Arsivi
, cilt.60, sa.3, ss.252-256, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202337. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)
Tuncer A., Kürtüncü M., Terzi M., UYGUNOĞLU U., Göncüoğlu C., Yüceyar A. N., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.323-332, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202338. The acute effect of cervical mobilization on balance in patients with multiple sclerosis: a single-blind, randomized, controlled trial
KARANFİL E., SALCI Y., FİL BALKAN A., Tuncer A., KARABUDAK R.
Neurological Research
, cilt.46, sa.1, ss.65-71, 2023 (SCI-Expanded, Scopus)
2023
202339. Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models
Şekerdağ-Kılıç E., Ulusoy C., Atak D., Özkan E., Gökyüzü A. B., Seyaj S., et al.
Multiple Sclerosis and Related Disorders
, cilt.69, 2023 (SCI-Expanded, Scopus)
2022
202240. Defining the experiences of adolescent patients with multiple sclerosis in transition from pediatric care to adult care
Yilmaz D. Y., YARDIMCI F., Erdemir F., KARABUDAK R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.68, 2022 (SCI-Expanded, Scopus)
2022
202241. Combined Central and Peripheral Demyelination in a Case With Sjogren Syndrome
SÖKMEN O., GÖÇMEN R., NURLU G., KARABUDAK R.
NEUROLOGIST
, cilt.27, sa.6, ss.354-356, 2022 (SCI-Expanded, Scopus)
2022
202242. Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Simpson-Yap S., Pirmani A., Kalincik T., De Brouwer E., Geys L., Parciak T., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, cilt.9, sa.6, 2022 (SCI-Expanded, Scopus)
2022
202243. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Zhu C., Zhou Z., Roos I., Merlo D., Kalincik T., ÖZAKBAŞ S., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.93, ss.1330-1337, 2022 (SCI-Expanded, Scopus)
2022
202244. Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta
Simpson-Yap S., Pirmani A., De Brouwer E., Peeters L. M., Geys L., Parciak T., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.66, 2022 (SCI-Expanded, Scopus)
2022
202245. A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
Ponzano M., Schiavetti I., Bovis F., Landi D., Carmisciano L., De Rossi N., et al.
Multiple Sclerosis and Related Disorders
, cilt.63, 2022 (SCI-Expanded, Scopus)
2022
202246. Hidden Markov Model and multifractal method-based predictive quantization complexity models vis-a-vis the differential prognosis and differentiation of Multiple Sclerosis' subgroups
Karaca Y., BALEANU D., KARABUDAK R.
KNOWLEDGE-BASED SYSTEMS
, cilt.246, 2022 (SCI-Expanded, Scopus)
2022
202247. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis An International Registry Study
Vitkova M., Diouf I., Malpas C., Horakova D., Havrdova E. K., Patti F., et al.
NEUROLOGY
, cilt.98, sa.24, 2022 (SCI-Expanded, Scopus)
2022
202248. Prediction of multiple sclerosis outcomes when switching to ocrelizumab
Zhong M., van der Walt A., Stankovich J., Kalincik T., Buzzard K., Skibina O., et al.
MULTIPLE SCLEROSIS JOURNAL
, cilt.28, sa.6, ss.958-969, 2022 (SCI-Expanded, Scopus)
2022
202249. Post-COVID-19 longitudinally extensive transverse myelitis: is it a new entity?
ARSLAN D., Acar-Ozen P., GÖÇMEN R., ELİBOL B., KARABUDAK R., Tuncer A.
NEUROLOGICAL SCIENCES
, cilt.43, sa.3, ss.1569-1573, 2022 (SCI-Expanded, Scopus)
2022
202250. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.58, 2022 (SCI-Expanded, Scopus)
2022
202251. Tumefactive demyelinating lesion in patient with neuromyelitis optica spectrum disorder
Topkan T. A., SÖKMEN O., Kocer B., KARABUDAK R., UYAR GÖÇÜN F. P.
NEUROLOGIA I NEUROCHIRURGIA POLSKA
, cilt.56, sa.3, ss.285-287, 2022 (SCI-Expanded, Scopus)
2022
202252. Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression
Sevim S., DEMİRKIRAN D. M., TERZİ M., YÜCEYAR A. N., Tasdelen B., İDİMAN E., et al.
ARQUIVOS DE NEURO-PSIQUIATRIA
, cilt.80, ss.168-172, 2022 (SCI-Expanded, Scopus)
2022
202253. Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
Arslan B., Arslan G. A., Tuncer A., KARABUDAK R., SEPİCİ DİNÇEL A.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES
, cilt.22, sa.5, ss.699-706, 2022 (SCI-Expanded, Scopus)
2021
202154. Factors associated with fingolimod rebound: A single center real-life experience
Goncuoglu C., Tuncer A., Bayraktar-Ekincioglu A., Cagan C. A., Acar-Ozen P., ÇAKAN M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.56, 2021 (SCI-Expanded, Scopus)
2021
202155. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018
Moradi N., Sharmin S., Malpas C., ÖZAKBAŞ S., Shaygannejad V., TERZİ M., et al.
CNS DRUGS
, cilt.35, sa.10, ss.1097-1106, 2021 (SCI-Expanded, Scopus)
2021
202156. Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Arslan B., Arslan G. A., Tuncer A., KARABUDAK R., SEPİCİ DİNÇEL A.
FRONTIERS IN NEUROLOGY
, cilt.12, 2021 (SCI-Expanded, Scopus)
2021
202157. The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies
Andersen J. B., Sharmin S., Lefort M., Koch-Henriksen N., Sellebjerg F., Sorensen P. S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.53, 2021 (SCI-Expanded, Scopus)
2020
202058. An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy
Acar N. P., Tuncer A., Ozkazanc D., Ozbay F. G., KARAOSMANOĞLU B., Goksen S., et al.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.347, 2020 (SCI-Expanded, Scopus)
2020
202059. Factors Affecting Bone Mineral Density in Male Patients with Primary Progressive Multiple Sclerosis
Arican A. C., Kutsal Y. G., Acar N. P., AKBIYIK F., KARAHAN S., KARABUDAK R.
TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS
, cilt.26, sa.2, ss.115-120, 2020 (ESCI, Scopus, TRDizin)
2020
202060. 'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'
Sevim S., Demirkiran M., TERZİ M., YÜCEYAR A. N., Tasdelen B., İDİMAN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.42, 2020 (SCI-Expanded, Scopus)
2020
202061. The COVID-19 from Neurological Overview
Acar T., Demirel E. A., AFSAR N., AKÇALI A., Demir G. A., ALAGÖZ A. N., et al.
TURKISH JOURNAL OF NEUROLOGY
, cilt.26, sa.2, ss.58-108, 2020 (ESCI, Scopus, TRDizin)
2020
202062. Early clinical markers of aggressive multiple sclerosis
Malpas C. B., Manouchehrinia A., Sharmin S., Roos I., Horakova D., Havrdova E. K., et al.
BRAIN
, cilt.143, ss.1400-1413, 2020 (SCI-Expanded, Scopus)
2020
202063. Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
SALCI Y., KARANFİL E., AYVAT E., Balkan A. F., KARAKAYA KARABULUT J., AKSOY S., et al.
TURKISH JOURNAL OF NEUROLOGY
, cilt.26, sa.1, ss.24-29, 2020 (ESCI, Scopus, TRDizin)
2020
202064. Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort
Vural A., Derle E., Sayat-Gurel G., KARABUDAK R., Tuncer A.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.38, 2020 (SCI-Expanded, Scopus)
2020
202065. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder
Kunchok A., Malpas C., Nytrova P., Havrdova E. K., Alroughani R., TERZİ M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.38, 2020 (SCI-Expanded, Scopus)
2020
202066. Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
Vural A., Okar S., Kurne A., Sayat-Gurel G., Acar N. P., KARABULUT E., et al.
MULTIPLE SCLEROSIS JOURNAL
, cilt.26, sa.1, ss.38-47, 2020 (SCI-Expanded, Scopus)
2019
201967. Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey
Kurtuncu M., Tuncer A., Uygunoglu U., Caliskan Z., Kokenli Paksoy A., EFENDİ H., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.56, sa.4, ss.269-272, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201968. Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
BOZ C., TERZİ M., Ozer B., Turkoglu R., KARABUDAK R., EFENDİ H., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.36, 2019 (SCI-Expanded, Scopus)
2019
201969. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
Kalincik T., Havrdova E. K., Horakova D., Izquierdo G., Prat A., Girard M., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.90, sa.4, ss.458-468, 2019 (SCI-Expanded, Scopus)
2019
201970. Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course
Kaymakamzade B., Kilic A. K., Tuncer Kurne A., KARABUDAK R.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.56, sa.1, ss.23-26, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201971. Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort
ÇOLPAK IŞIKAY A. İ., GÜLMEZ SEVİM D., Tuncer A., Diker S., KARABUDAK R., Kadayificilar S., et al.
TURKISH JOURNAL OF NEUROLOGY
, cilt.25, sa.1, ss.26-31, 2019 (ESCI, Scopus, TRDizin)
2019
201972. Are there any clinical and electrocardiographic predictors of heart rate reduction in relapsing- remitting multiple sclerosis patients treated with fingolimod?
Kocyigit D., YALÇIN M. U., Gurses K. M., Tokgozoglu L., KARABUDAK R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.27, ss.276-280, 2019 (SCI-Expanded, Scopus)
2018
201873. Cerebrospinal fluid oligoclonal banding patterns and intrathecal immunoglobulin synthesis: Data comparison from a wide patient group
PINAR A., Kurne A. T., LAY İ., Acar N. P., KARAHAN S., KARABUDAK R., et al.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, cilt.35, sa.1, ss.21-28, 2018 (SCI-Expanded, Scopus, TRDizin)
2017
201774. Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia
SALCI Y., FİL BALKAN A., KEKLİCEK H., ÇETİN B., ARMUTLU K., Dolgun A., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.18, ss.135-140, 2017 (SCI-Expanded, Scopus)
2017
201775. Multiple Skleroz Hastalarının Tamamlayıcı ve Alternatif Tedavi Kullanım Durumlarının Belirlenmesi.
DURU AŞİRET G., Düğer ü., KAPUCU S., TUNCER M. A., KARABUDAK R.
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi , cilt.6, sa.3, ss.1-6, 2017 (TRDizin)
2017
201776. Effects of different exercise modalities on ataxia in multiple sclerosis patients: a randomized controlled study
SALCI Y., FİL BALKAN A., ARMUTLU K., Yildiz F. G., Kurne A., AKSOY S., et al.
DISABILITY AND REHABILITATION
, cilt.39, sa.26, ss.2626-2632, 2017 (SCI-Expanded, SSCI, Scopus)
2017
201777. Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
Dahdaleh M., Alroughani R., Aljumah M., AlTahan A., Alsharoqi I., Bohlega S. A., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, cilt.127, sa.10, ss.944-951, 2017 (SCI-Expanded, Scopus)
2016
201678. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome
Diker S., Has A. C., Kurne A., GÖÇMEN R., Oguz K. K., KARABUDAK R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.10, ss.14-21, 2016 (SCI-Expanded, Scopus)
2016
201679. Unfavorable outcome of pediatric onset multiple sclerosis: Follow-up in the pediatric and adult neurology departments of one referral center, in Turkey
Derle E., Kurne A. T., KONUŞKAN B., KARABUDAK R., Anlar B.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.9, ss.1-4, 2016 (SCI-Expanded, Scopus)
2016
201680. Acute Disseminated Encephalomyelitis after Oral Therapy with Herbal Extracts: A Case Report
Kaymakamzade B., KARABUDAK R., Kurne A. T., NURLU G.
BALKAN MEDICAL JOURNAL
, cilt.33, sa.3, ss.366-369, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201681. Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin
Vural A., GÖÇMEN R., KURNE A. T., OGUZ K. K., TEMUÇİN Ç. M., TAN E., et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
, cilt.43, sa.1, ss.149-156, 2016 (SCI-Expanded, Scopus)
2016
201682. Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
Alroughani R., Altintas A., Al Jumah M., Sahraian M., Alsharoqi I., AlTahan A., et al.
MULTIPLE SCLEROSIS INTERNATIONAL
, cilt.2016, 2016 (ESCI)
2016
201683. Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome
Durhan G., Diker S., Has A. C., Karakaya J., Kurne A. T., KARABUDAK R., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, cilt.126, sa.9, ss.805-811, 2016 (SCI-Expanded, Scopus)
2016
201684. Case Study Application for C-Support Vector Classification: The Estimation of MS Subgroup Classification with Selected Kernels and Parameters
Karaca Y., Hayta S., KARABUDAK R.
EUROPEAN JOURNAL OF PURE AND APPLIED MATHEMATICS
, cilt.9, sa.2, ss.196-215, 2016 (ESCI, Scopus)
2015
201585. Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants
ERDENER Ş. E., KURNE A. T., DIKER S., KARABUDAK R.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, cilt.359, ss.106-107, 2015 (SCI-Expanded, Scopus)
2015
201586. Magnetic Resonance Imaging as a Major Milestone in Multiple Sclerosis Diagnosis and Treatment
KARABUDAK R.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.52, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201587. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort Demographic, Clinical, and Laboratory Features
Altintas A., KARABUDAK R., Balci B. P., TERZİ M., Soysal A., Saip S., et al.
NEUROLOGIST
, cilt.20, sa.4, ss.61-66, 2015 (SCI-Expanded, Scopus)
2015
201588. Functional clinical outcomes in multiple sclerosis: Current status and future prospects
KARABUDAK R., Dahdaleh M., Aljumah M., Alroughani R., Alsharoqi I. A., AlTahan A. M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.4, sa.3, ss.192-201, 2015 (SCI-Expanded, Scopus)
2015
201589. Linear Modeling of Multiple Sclerosis and Its Subgroubs
Karaca Y., OSMAN O., KARABUDAK R.
TURKISH JOURNAL OF NEUROLOGY
, cilt.21, sa.1, ss.7-12, 2015 (ESCI, Scopus)
2015
201590. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey
KARABUDAK R., Karampampa K., Caliskan Z.
JOURNAL OF MEDICAL ECONOMICS
, cilt.18, sa.1, ss.69-75, 2015 (SCI-Expanded, Scopus)
2015
201591. Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide
KILIÇ A., ESENDAĞLI G., SAYAT G., TALİM B., KARABUDAK R., KURNE A.
AUTOIMMUNITY
, cilt.48, sa.6, ss.423-428, 2015 (SCI-Expanded, Scopus)
2014
201492. The Course of Myasthenia Gravis with Systemic Lupus Erythematosus
Bekircan-Kurt C. E., Kurne A. T., Erdem-Ozdamar S., Kalyoncu U., Karabudak R., Tan E.
EUROPEAN NEUROLOGY
, cilt.72, ss.326-329, 2014 (SCI-Expanded, Scopus)
2013
201393. Mass Lesions in the Brain: Tumor or Multiple Sclerosis? Clinical and Imaging Characteristics and Course from a Single Reference Center
Kilic A. K., Tuncer Kurne A., Karli Oguz K., Soylemezoglu F., KARABUDAK R.
TURKISH NEUROSURGERY
, cilt.23, sa.6, ss.728-735, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201394. Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy
ESENDAĞLI G., Kurne A. T., Sayat G., Kilic A. K., Guc D., KARABUDAK R.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.255, ss.81-84, 2013 (SCI-Expanded, Scopus)
2013
201395. Comparing routine neurorehabilitation program with trunk exercises based on Bobath concept in multiple sclerosis: Pilot study
Keser I., Kirdi N., Meric A., Kurne A. T., Karabudak R.
JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
, cilt.50, sa.1, ss.133-140, 2013 (SCI-Expanded, SSCI, Scopus)
2013
201396. Myasthenia Gravis; Single Entity, Variable Clinical Features: Ten Years of Clinical Experience in a Tertiary Care Center Ten Years Clinical Experience of a Tertiary Care Center
BEKIRCAN-KURT C. E., KURNE A., ERDEM ÖZDAMAR S., KARABUDAK R., KANSU T., TAN E.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, cilt.30, sa.1, ss.135-143, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201297. Lack of association of the CD14/C-159T polymorphism with susceptibility and progression parameters in Turkish multiple sclerosis patients
Kurne A., Sayat G., Aydin O. F., Turgutoglu N., Terzi M., Sackesen C., et al.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.250, ss.83-86, 2012 (SCI-Expanded, Scopus)
2012
201298. Involvement of Autonomic Nervous System and its Relationship With Cranial and Cervical Spinal MRI Findings In Patients With Multiple Sclerosis
Ciftci O., KESER İ., Kurne A., Bosnak Guclu M., Karli Oguz K., Soylu R., et al.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, cilt.29, sa.2, ss.181-191, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
201199. Improvement of muscle strength and fatigue with high voltage pulsed galvanic stimulation in multiple sclerosis patients - a non-randomized controlled trial
Korkmaz N. C., Kirdi N., TEMUÇİN Ç. M., ARMUTLU K., Yakut Y., KARABUDAK R.
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
, cilt.61, sa.8, ss.736-743, 2011 (SCI-Expanded, Scopus)
2011
2011100. Comparing routine neurorehabilitation programme with callisthenic exercises in multiple sclerosis
KESER İ., MERİÇ A., KIRDI N., Kurne A., KARABUDAK R.
NEUROREHABILITATION
, cilt.29, sa.1, ss.91-98, 2011 (SCI-Expanded, SSCI, Scopus)
2011
2011101. Analysis of BAFF and TRAIL expression levels in multiple sclerosis patients: evaluation of expression under immunomodulatory therapy
Kurne A., Guc D., CANPINAR H., Aydin O. F., Sayat G., Yorubulut M., et al.
ACTA NEUROLOGICA SCANDINAVICA
, cilt.123, sa.1, ss.8-12, 2011 (SCI-Expanded, Scopus)
2010
2010102. A comparative assessment of cerebral white matter by magnetization transfer imaging in early- and adult-onset multiple sclerosis patients matched for disease duration
Oguz K. K., Kurne A., Aksu A. O., Taskiran A., KARABULUT E., KARABUDAK R.
JOURNAL OF NEUROLOGY
, cilt.257, sa.8, ss.1309-1315, 2010 (SCI-Expanded, Scopus)
2010
2010103. Familial Mediterranean fever and central nervous system involvement: a case series.
KALYONCU U., Eker A., Oguz K. K., Kurne A., Kalan I., Topcuoglu A. M., et al.
Medicine
, cilt.89, sa.2, ss.75-84, 2010 (SCI-Expanded, Scopus)
2010
2010104. Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients
Kurne A., KARABUDAK R., YALÇIN ÇAKMAKLI G., Gursoy-Ozdemir Y., Aydin P., Ilksen-Colpak A., et al.
EYE AND BRAIN
, cilt.2, ss.15-20, 2010 (ESCI, Scopus)
2010
2010105. Cumulative Corticosteroid Doses and Osteoporosis in Patients with Multiple Sclerosis
Arslan S., Celiker R., KARABUDAK R.
TURKISH JOURNAL OF RHEUMATOLOGY
, cilt.25, sa.4, ss.191-195, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010106. The Effect of Walking Distance on EDSS Score in Patients with Multiple Sclerosis
Tombak K. B., ARMUTLU K., KARABUDAK R.
TURKISH JOURNAL OF NEUROLOGY
, cilt.16, sa.2, ss.72-77, 2010 (ESCI, Scopus, TRDizin)
2009
2009107. An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis
Kurne A., KARABUDAK R., KARADAĞ Ö., Yalcin-Cakmakli G., Karli-Oguz K., Yavuz K., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.29, sa.11, ss.1349-1353, 2009 (SCI-Expanded, Scopus)
2009
2009108. The validity and test-retest reliability of the Leeds Multiple Sclerosis Quality of Life scale in Turkish patients
Akbiyik D. I., Sumbuloglu V., Guney Z., ARMUTLU K., Korkmaz N., KESER İ., et al.
INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
, cilt.32, sa.2, ss.162-166, 2009 (SSCI, Scopus)
2009
2009109. Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
Kurne A., TERZİ M., Aydin O. F., ONAR M. K., KARABUDAK R.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, cilt.26, sa.2, ss.131-138, 2009 (SCI-Expanded, Scopus, TRDizin)
2009
2009110. Use of Mitoxantrone in Early Secondary Progressive Multiple Sclerosis: An Observational Study of 48 Patients with Clinical and MRI Outcomes
Kilic A. K., Kurne A., BAŞTAN B., Cikrikci I., Bas D. F., Bulus M., et al.
TURKISH JOURNAL OF NEUROLOGY
, cilt.15, sa.2, ss.64-70, 2009 (ESCI, TRDizin)
2008
2008111. A clinically isolated syndrome: A challenging entity
Kurne A., Isikay I. C., Karlioguz K., KALYONCU U., AYDIN Ö. F., Calguneri M., et al.
JOURNAL OF NEUROLOGY
, cilt.255, sa.11, ss.1625-1635, 2008 (SCI-Expanded, Scopus)
2008
2008112. Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy
Kurne A., Aydin O. F., Guec D., Sayat G., Canpinar H., Yoeruebulut M., et al.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.203, sa.2, ss.137-138, 2008 (SCI-Expanded, Scopus)
2008
2008113. Recurrent alien hand syndrome in a multiple sclerosis case
Kurne A., Cakmakli G. Y., KARABUDAK R.
NEUROLOGIST
, cilt.14, sa.5, ss.316-317, 2008 (SCI-Expanded, Scopus)
2008
2008114. Evaluating the Existence of Other Autoimmune Diseases Among Multiple Sclerosis Patients and Their First Degree Relatives
Kurne A., Terzi M., Erturk O., Onar M., Dogan B. G., KARABUDAK R.
TURKISH JOURNAL OF NEUROLOGY
, cilt.14, sa.2, ss.104-109, 2008 (ESCI, TRDizin)
2007
2007115. Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
Goodin D. S., Biermann L. D., Bohlega S., Boiko A., Chofflon M., Gebeily S., et al.
CURRENT MEDICAL RESEARCH AND OPINION
, cilt.23, sa.11, ss.2823-2832, 2007 (SCI-Expanded, Scopus)
2007
2007116. White matter alteration in a patient with Graves' disease
Kurne A., Aydin O. F., Karabudak R.
JOURNAL OF CHILD NEUROLOGY
, cilt.22, sa.9, ss.1128-1131, 2007 (SCI-Expanded, Scopus)
2007
2007117. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients
Armutlu K., Keser I., Koikmaz N., Akbiyik D. I., Sumbuloglu V., Guney Z., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, cilt.255, ss.64-68, 2007 (SCI-Expanded, Scopus)
2007
2007118. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients
Armutlu K., Korkmaz N. C., Keser I., Sumbuloglu V., Akbiyik D. I., Guney Z., et al.
INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
, cilt.30, sa.1, ss.81-85, 2007 (SSCI, Scopus)
2006
2006119. Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of "AIDS-toxoplasmosis complex"
OEZKAYA G., Kurne A., Uenal S., Oguz K. K., Karabudak R., Saygi S.
EPILEPSY & BEHAVIOR
, cilt.9, sa.1, ss.193-196, 2006 (SCI-Expanded, Scopus)
2006
2006120. Steps in the Pathogenesis of Multiple Sclerosis - I: From Neuroinflammation to Neurodegeneration
Kurne A., KARABUDAK R., AYDIN Ö. F.
TURKISH JOURNAL OF NEUROLOGY
, cilt.12, sa.1, ss.5-13, 2006 (ESCI, TRDizin)
2006
2006121. Steps in Multiple Sclerosis Pathogenesis - II: The Role of Biological Markers, Sodium Channels and Glutamate in Neurodegeneration
AYDIN Ö. F., Kurne A., KARABUDAK R.
TURKISH JOURNAL OF NEUROLOGY
, cilt.12, sa.2, ss.98-105, 2006 (ESCI, TRDizin)
2006
2006122. The colorful clinical spectrum of cerebral toxoplasmosis in five HIV positive cases: What comes out of Pandora's box? HIV pozitif beş olguda serebral toksoplazmozisin renkli klinigi: Pandora'nιn kutusundan çιkanlar
Kurne A., Özkaya G., Karlioǧuz K., Shorbagi A., Ustaçelebi Ş., KARABUDAK R., et al.
Mikrobiyoloji Bulteni
, cilt.40, sa.1-2, ss.85-92, 2006 (Scopus)
2004
2004123. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients - One year follow-up results
KARABUDAK R., KURNE A., GUC D., Sengelen M., CANPINAR H., KANSU E.
JOURNAL OF NEUROLOGY
, cilt.251, sa.3, ss.279-283, 2004 (SCI-Expanded, Scopus)
2000
2000124. Multiphasic disseminated encephalomyelitis: A 4-year follow-up
Ünal I., DOǦULU F. Ç., SAYGI S., FIRAT M., RUACAN Ş., KARABUDAK R.
European Neurology
, cilt.43, sa.1, ss.55-58, 2000 (SCI-Expanded, Scopus)
1997
1997125. Familial Mediterranean fever and multiple sclerosis
TOPÇUOĞLU M. A., KARABUDAK R.
JOURNAL OF NEUROLOGY
, cilt.244, sa.8, ss.510-514, 1997 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. Low disability accumulation after 4-year ocrelizumab therapy in treatment-naive patients with early-stage relapsing-remitting multiple sclerosis; data from the Phase IIIb ENSEMBLE study
Patti F., Bermel R., Brochet B., Berger T., Carroll W., Freedman M. S., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.594-596, (Özet Bildiri)
2023
20232. The Effect of Pregnancy on Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Associated Disease Activity and Progression: A Multi-center Retrospective Study from Turkey
Uzunkopru C., Şen S., Altintas A., ÇAKAN ERCAN M., BÜNÜL S. D., Demir G. A., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.664, (Özet Bildiri)
2023
20233. Clinical Features, Treatment and Outcomes of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) - An Experience from a Tertiary Center
Ozbek E. D., ACAR ÖZEN N. P., GÖÇMEN R., Tan E., KARABUDAK R., TUNCER M. A.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.654, (Özet Bildiri)
2023
20234. Evaluation of Nutritional Status in Patients with Multiple Sclerosis
ATABİLEN B., AKDEVELİOĞLU Y., ACAR ÖZEN N. P., KARABUDAK R., TUNCER M. A.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.1043-1044, (Özet Bildiri)
2023
20235. The Impact of COVID-19 Infection on Multiple Sclerosis Disease Course: A Propensity-Matched Cohort Study
Levitz D., Foong Y. C., Sanfilippo P., Spelman T., Rath L., Roldan A., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.1046-1048, (Özet Bildiri)
2023
20236. Comparison of Clinical Features of Aquaporin-4 Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein (MOG) Associated Disorder, and Seronegative NMOSD - A Single Center Experience
Ozbek E. D., ÇAKAN ERCAN M., ACAR ÖZEN N. P., ÇOLPAK IŞIKAY A. İ., KAŞIKCI ÇAVDAR M., KARABUDAK R., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.660-661, (Özet Bildiri)
2023
20237. Disease activity during pre-conception, pregnancy and postpartum in women with MS receiving ocrelizumab or other disease-modifying therapies in a real-world cohort
Yeh W., Van der Walt A., Skibina O., Kermode A., Pedrini M., Kalincik T., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.129-132, (Özet Bildiri)
2021
20218. Real World Ocrelizumab Experience of a Tertiary Center in Turkey
ARSLAN D., Acar-Ozen N. P., KARABUDAK R., Tuncer A.
Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 Nisan 2021, cilt.96, (Özet Bildiri)
2019
20199. DİNAMİK KONTRAST MR PERMEABİLİTE GÖRÜNTÜLEMENİN NÖROMYELİTİS OPTİKA SPEKTRUM HASTALARINDA AQUAPORİN KANAL DİSFONKSİYONUNUN GÖSTERİLMESİNDE YERİ OLABİLİR Mİ ?
OKAR S. V., GÖÇMEN R., PARLAK Ş., ERDENER Ş. E., KARLI OĞUZ H. K., KARABUDAK R., et al.
55. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)
2019
201910. HEMORAJİK LONGİTUDİNAL EKSTENSİF TRANSVERS MİYELİT: 4 OLGU
YILMAZ E., GÖÇMEN R., KARABUDAK R., KARLI OĞUZ H. K., TUNCER M. A.
55. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)
2019
201911. Dinamik Kontrast MR Permeabilite Görüntülemenin Nöromyelitis Optika Spektrum Hastalarında Aquaporin Kanal Disfonksiyonunun Gösterilmesinde Yeri Olabili rmi
Okar S., GÖÇMEN R., PARLAK Ş., ERDENER Ş. E., KARLI OĞUZ H. K., KARABUDAK R., et al.
55. Ulusal Nöroloji Kongresi, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)
2019
201912. Transcriptomic and immunophenotypic analyses on natural killer cells in RRMS patients under fingolimod therapy
Acar-Ozen N. P., TUNCER A., Ozkazanc D., Ozbay F. G., KARAOSMANOĞLU B., Goksen S., et al.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.664-665, (Özet Bildiri)
2019
201913. BK virus can be neurotropic: a rare cause of PML
AYVACIOĞLU C., KARABUDAK R., TUNCER A., ÖGE D. D., ELİBOL B., Tan E., et al.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.836, (Özet Bildiri)
2018
201814. Radyolojik İzole Sendromlu Bireylerde Temporal Peripapiller Retinal Sinir Lifi Tabakası Kalınlığının Azalması ve Beyin Hacim Kaybı ile İlişkisi
VURAL A., Okar S., TUNCER M. A., Sayat G., Acar N. P., KARABULUT E., et al.
54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)
2018
201815. ANN Classification of MS Subgroups with Diffusion Limited Aggregation
Karaca Y., Cattani C., KARABUDAK R.
18th International Conference on Computational Science and Its Applications (ICCSA), Melbourne, Avustralya, 2 - 05 Temmuz 2018, cilt.10961, ss.121-136, (Tam Metin Bildiri)
2017
201716. Can MR Permeabiltiy and Contast Enhanced (CE)-FLAIR demonstrate AQP4 Channel Dysfuncton NMOSD Patents?: Work in Progress
OKAR S. V., GÖÇMEN R., TUNCER M. A., KARLI OĞUZ H. K., ERDENER Ş. E., KARABUDAK R.
MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, Fransa, 25 - 28 Ekim 2017, (Özet Bildiri)
2017
201717. Can MR permeability and contast enhanced (CE)-FLAIR demonstrate AQP4 channel dysfunction in NMOSD patients? Work in progress
OKAR S. V., GÖÇMEN R., KARLI-OGUZ K., TUNCER M., Erdener S. E., KARABUDAK R.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.819-820, (Özet Bildiri)
2017
201718. Spectrum of autoantibodies against myelin oligodendrocyte glycoprotein
VURAL A., TUNCER M. A., M SPADARO M., KONUŞKAN B., GÖÇMEN R., ANLAR F. B., et al.
3rd Congress of the European Academy of Neurology, Amsterdam, Hollanda, 24 - 27 Haziran 2017, cilt.24, ss.19-122, (Özet Bildiri)
2016
201619. The Maculo-Papillary Bundle and Inner Ganglion Cell Layer Are Affected More Prominently in Radiologically Isolated Syndrome
KARABUDAK R., Vural A., Acar N. P., TUNCER M. A., Sayat G., KADAYIFÇILAR S.
9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.326, (Özet Bildiri)
2016
201620. The effect of fingolimod treatment on natural killer cells
Acar N. P., KARABUDAK R., Ozkazanc D., Sayat-Gurel G., ESENDAĞLI G., TUNCER A.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, cilt.22, ss.176-177, (Özet Bildiri)
2016
201621. Leptomeningeal contrast enhancement in patients with neuromyelitis optica disorder
OKAR S. V., TUNCER M. A., GÖÇMEN R., ÇOLPAK IŞIKAY A. İ., yılmaz e., KARABUDAK R.
32ND CoNgressof the europeaN Committeefor treatmeNt aND researChiN multiple sClerosis, Londrina, Brezilya, 14 Haziran - 17 Eylül 2016, (Özet Bildiri)
2016
201622. Factors Affecting Bone Mineral Density Among Male Primary Progressive Multiple Sclerosis Patients
ÇALIŞKAN A., KUTSAL F. Y., ACAR P., KARABUDAK R., AKBIYIK F., KARAHAN S.
WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Malaga, İspanya, 14 - 17 Nisan 2016, cilt.27, (Özet Bildiri)
2016
201623. Disease activity in Primary Progressive Multiple Sclerosis
Vural A., Kurne A. T., Sayat G., Derle E., KARABUDAK R.
ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.30, (Özet Bildiri)
2014
201424. Rituximab experience in neuromyelitis optica: data from a single center in Turkey
ERDENER Ş. E., DIKER S., KARABUDAK R., KURNE A. T.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.454, (Özet Bildiri)
2013
201325. Formyl-methionyl-leucyl-phenylalanine (fMLP) peptide as an adjuvant in experimental autoimmune encephalomyelitis (EAE): modulation of neutrophil granulocytes
KILIÇ A., Tuncer-Kurne A., ESENDAĞLI G., Sayat G., TALİM B., KARABUDAK R.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, cilt.19, ss.136, (Özet Bildiri)
2013
201326. Inflammatory pan-demyelination syndrome IPANDS of the whole nervous system
Vural A., GÜLER E., GÖÇMEN R., TUNCER M. A., KARLI OĞUZ H. K., TEMUÇİN Ç. M., et al.
2013 Meeting of the Peripheral Nerve Society, Fransa, 29 Haziran - 03 Temmuz 2013, cilt.18, ss.1-131, (Özet Bildiri)
2012
201227. Evaluation of Th17-related parameters in multiple sclerosis patients under immunomodulatory IFN-beta 1 therapy
Sayat G., Kurne A., ESENDAĞLI G., Guc D., KARABUDAK R.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.77-78, (Özet Bildiri)
2008
200828. Walking and Expanded Disability Status Scale: are self-estimated walking distances accurate?
Armuthu K., Balci K., FİL BALKAN A., KARABUDAK R.
13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Kanada, 17 - 20 Eylül 2008, cilt.14, (Özet Bildiri)
2008
200829. TRAIL and BAFF serial serum levels during interferon beta therapy in MS patients
Kurne A., CANPINAR H., Aydin O. F., Sayat G., Yoeruebulut M., Guec D., et al.
13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Kanada, 17 - 20 Eylül 2008, cilt.14, (Özet Bildiri)
2008
200830. The effects of high-voltage pulsed galvanic stimulation on fatigue in multiple sclerosis patients
KORKMAZ N. Ç., ARMUTLU K., KESER İ., KIRDI N., KARABUDAK R.
13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Kanada, 17 - 20 Eylül 2008, cilt.14, (Özet Bildiri)
2007
200731. Clinical and prognostic features of bilateral and unilateral recurrent optic neuritis
TUNCER M. A., YALÇIN ÇAKMAKLI G., KARABUDAK R., Aydın P., Kansu T.
8th European Neuro-opthalmology Society (EUNOS) Meeting, İstanbul, Türkiye, 26 - 29 Mayıs 2007, cilt.31, (Özet Bildiri)
2006
200632. Operküler sendrom ile kendini gösteren santral sinir sistemi vasküliti
YALÇIN ÇAKMAKLI G., GÜREL Ş. C., ÇOLPAK IŞIKAY A. İ., SAYGI S., KARABUDAK R., SÖYLEMEZOĞLU A. F., et al.
42. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 12 - 17 Kasım 2006, cilt.12, ss.103-104, (Özet Bildiri)
2002
200233. Yabancı el sendromunun farklı yüzleri
YALÇIN ÇAKMAKLI G., YILDIZ SARIKAYA F. G., BAŞ D. F., TUNCER M. A., TOPÇUOĞLU M. A., KARABUDAK R., et al.
42. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 12 Kasım 2002 - 17 Kasım 2006, cilt.12, ss.77-78, (Özet Bildiri)
2006
200634. Type I diabetes mellitus and central nervous system demyelinization: A possible association
Kurne A., Basak E. S., Karabudak R.
8th International Conference of Neuroimmunology, Nagoya, Japonya, 15 - 19 Ekim 2006, cilt.178, ss.264, (Özet Bildiri)
2006
200635. The role of sodium in predicting HIV related neurological complications
Kurne A., Sahin G. O., Karlioguz K., Sahin S. U., Karabudak R.
8th International Conference of Neuroimmunology, Nagoya, Japonya, 15 - 19 Ekim 2006, cilt.178, ss.259-260, (Özet Bildiri)
Desteklenen Projeler
2015 - 2019
2015 - 2019Multiple Skleroz Hastalarında CCRL2 Atipik Kemokin Reseptör Polimorfizminin Kemokin Düzeyleri ve Hastalık Süreci ile İlişkisi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
TUNCER M. A. (Yürütücü), ACAR N. P., ESENDAĞLI G., SAYAT-GÜREL G., KARABUDAK R.
2015 - 2016
2015 - 2016Erkek primer progresif multiple skleroz(MS) olgularında kemik mineral yoğunluğu (KMD) ile etkileşen faktörler
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KUTSAL F. Y. (Yürütücü), ÇALIŞKAN A., KARABUDAK R., AKBIYIK F., ACAR N. P., KARAHAN S.